Magnetic resonance spectroscopy investigations of functionally defined language areas in schizophrenia patients with and without auditory hallucinations

NeuroImage

Volumn 94, Issue , 2014, Pages 23-32

  Homan, Philipp ^a   Vermathen, Peter ^b   Van Swam, Claudia ^a   Federspiel, Andrea ^a   Boesch, Chris ^b   Strik, Werner ^a   Dierks, Thomas ^a   Hubl, Daniela ^a   Kreis, Roland ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Auditory hallucinations; Language; Magnetic resonance spectroscopy; Myo inositol; N acetyl aspartate; Schizophrenia

Indexed keywords

INOSITOL; N ACETYLASPARTIC ACID; ASPARTIC ACID; BIOLOGICAL MARKER; N-ACETYLASPARTATE;

ADULT; ARTICLE; AUDITORY HALLUCINATION; BRAIN FUNCTION; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGONAL BAND OF BROCA; FEMALE; FRONTAL CORTEX; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HESCHL GYRUS; HUMAN; IMAGE QUALITY; LANGUAGE; MALE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; RELIABILITY; SCHIZOPHRENIA; TASK PERFORMANCE; TEMPORAL LOBE; VERBALIZATION; WERNICKE AREA; ANALOGS AND DERIVATIVES; BRAIN MAPPING; COMPLICATION; HALLUCINATIONS; METABOLISM; MIDDLE AGED; MOLECULAR IMAGING; NERVE CELL NETWORK; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOPHYSIOLOGY; PROCEDURES; PROTON NUCLEAR MAGNETIC RESONANCE;

ADULT; ASPARTIC ACID; BIOLOGICAL MARKERS; BRAIN MAPPING; BROCA AREA; FEMALE; HALLUCINATIONS; HUMANS; LANGUAGE; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MOLECULAR IMAGING; NERVE NET; PROTON MAGNETIC RESONANCE SPECTROSCOPY; SCHIZOPHRENIA; WERNICKE AREA;

EID: 84898652869     PISSN: 10538119     EISSN: 10959572     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2014.03.009     Document Type: Article

References (50)

1. Abbott C., Bustillo J. What have we learned from proton magnetic resonance spectroscopy about schizophrenia? A critical update. Curr. Opin. Psychiatry 2006, 19:135-139.
2. Adalsteinsson E., Sullivan E.V., Kleinhans N., Spielman D.M., Pfefferbaum A. Longitudinal decline of the neuronal marker N-acetyl aspartate in Alzheimer's disease. Lancet 2000, 355:1696-1697.
3. Allen E.A., Erhardt E.B., Wei Y., Eichele T., Calhoun V.D. Capturing inter-subject variability with group independent component analysis of fMRI data: a simulation study. Neuroimage 2012, 59:4141-4159.
4. Allen P., Modinos G., Hubl D., Shields G., Cachia A., et al. Neuroimaging auditory hallucinations in schizophrenia: from neuroanatomy to neurochemistry and beyond. Schizophr. Bull. 2012, 38:695-703.
5. Amunts K., Malikovic A., Mohlberg H., Schormann T., Zilles K. Brodmann's areas 17 and 18 brought into stereotaxic space-where and how variable?. Neuroimage 2000, 11:66-84.
6. Aronson R., Offman H.J., Joffe R.T., Naylor C.D. Triiodothyronine augmentation in the treatment of refractory depression. A meta-analysis. Arch. Gen. Psychiatry 1996, 53:842-848.
7. Barker P.B., Bizzi A., De Stefano N., Gullapali R.P., Lin D.D.M. Clinical MR Spectroscopy. Techniques and Applications 2009, Cambridge University Press.
8. Bauer M., Whybrow P.C. Thyroid hormone, neural tissue and mood modulation. World J. Biol. Psychiatry 2001, 2:59-69.
9. Bertolino A., Callicott J.H., Mattay V.S., Weidenhammer K.M., Rakow R., et al. The effect of treatment with antipsychotic drugs on brain N-acetylaspartate measures in patients with schizophrenia. Biol. Psychiatry 2001, 49:39-46.
10. Bhakoo K.K. N-acetyl-aspartate (NAA) metabolism. Advances in Neurobiology 2012, 1075-1093. Springer, New York. A. Lathja (Ed.).
11. Bottomley, P.A., 1984. Selective volume method for performing localized NMR spectroscopy, US Patent 4 480 228. USA.
12. Bracken B.K., Rouse E.D., Renshaw P.F., Olson D.P. T2 relaxation effects on apparent N-acetylaspartate concentration in proton magnetic resonance studies of schizophrenia. Psychiatry Res. 2013, 213:142-153.
13. Brand A., Richter-Landsberg C., Leibfritz D. Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev. Neurosci. 1993, 15:289-298.
14. Braus D.F., Ende G., Weber-Fahr W., Demirakca T., Henn F.A. Favorable effect on neuronal viability in the anterior cingulate gyrus due to long-term treatment with atypical antipsychotics: an MRSI study. Pharmacopsychiatry 2001, 34:251-253.
15. Braus D.F., Ende G., Weber-Fahr W., Demirakca T., Tost H., et al. Functioning and neuronal viability of the anterior cingulate neurons following antipsychotic treatment: MR-spectroscopic imaging in chronic schizophrenia. Eur. Neuropsychopharmacol. 2002, 12:145-152.
16. Brugger S., Davis J.M., Leucht S., Stone J.M. Proton magnetic resonance spectroscopy and illness stage in schizophrenia-a systematic review and meta-analysis. Biol. Psychiatry 2011, 69:495-503.
17. Burton M.W., Noll D.C., Small S.L. The anatomy of auditory word processing: individual variability. Brain Lang. 2001, 77:119-131.
18. Chang L., Friedman J., Ernst T., Zhong K., Tsopelas N.D., et al. Brain metabolite abnormalities in the white matter of elderly schizophrenic subjects: implication for glial dysfunction. Biol. Psychiatry 2007, 62:1396-1404.
19. Chong D.G., Kreis R., Bolliger C.S., Boesch C., Slotboom J. Two-dimensional linear-combination model fitting of magnetic resonance spectra to define the macromolecule baseline using FiTAID, a Fitting Tool for Arrays of Interrelated Datasets. MAGMA 2011, 24:147-164.
20. Copolov D., Trauer T., Mackinnon A. On the non-significance of internal versus external auditory hallucinations. Schizophr. Res. 2004, 69:1-6.
21. Delamillieure P., Constans J.M., Fernandez J., Brazo P., Benali K., et al. Proton magnetic resonance spectroscopy (1H MRS) in schizophrenia: investigation of the right and left hippocampus, thalamus, and prefrontal cortex. Schizophr. Bull. 2002, 28:329-339.
22. Derrfuss J., Brass M., von Cramon D.Y., Lohmann G., Amunts K. Neural activations at the junction of the inferior frontal sulcus and the inferior precentral sulcus: interindividual variability, reliability, and association with sulcal morphology. Hum. Brain Mapp. 2009, 30:299-311.
23. Dierks T., Linden D.E., Jandl M., Formisano E., Goebel R., et al. Activation of Heschl's gyrus during auditory hallucinations. Neuron 1999, 22:615-621.
24. Ende G., Braus D.F., Walter S., Weber-Fahr W., Soher B., et al. Effects of age, medication, and illness duration on the N-acetyl aspartate signal of the anterior cingulate region in schizophrenia. Schizophr. Res. 2000, 41:389-395.
25. Fedorenko E., Hsieh P.J., Nieto-Castanon A., Whitfield-Gabrieli S., Kanwisher N. New method for fMRI investigations of language: defining ROIs functionally in individual subjects. J. Neurophysiol. 2010, 104:1177-1194.
26. Heckers S. Neuroimaging studies of the hippocampus in schizophrenia. Hippocampus 2001, 11:520-528.
27. Homan P., Kindler J., Federspiel A., Flury R., Hubl D., et al. Muting the voice: a case of arterial spin labeling-monitored transcranial direct current stimulation treatment of auditory verbal hallucinations. Am. J. Psychiatry 2011, 168:853-854.
28. Homan P., Kindler J., Hubl D., Dierks T. Auditory verbal hallucinations: imaging, analysis, and intervention. Eur. Arch. Psychiatry Clin. Neurosci. 2012, 262(Suppl. 2):91-95.
29. Hor K., Taylor M. Suicide and schizophrenia: a systematic review of rates and risk factors. J. Psychopharmacol. 2010, 24:81-90.
30. Hubl D., Koenig T., Strik W., Federspiel A., Kreis R., et al. Pathways that make voices: white matter changes in auditory hallucinations. Arch. Gen. Psychiatry 2004, 61:658-668.
31. Hubl D., Koenig T., Strik W.K., Garcia L.M., Dierks T. Competition for neuronal resources: how hallucinations make themselves heard. Br. J. Psychiatry 2007, 190:57-62.
32. Jansen J.F., Backes W.H., Nicolay K., Kooi M.E. 1H MR spectroscopy of the brain: absolute quantification of metabolites. Radiology 2006, 240:318-332.
33. Jung R.E., Yeo R.A., Chiulli S.J., Sibbitt W.L., Weers D.C., et al. Biochemical markers of cognition: a proton MR spectroscopy study of normal human brain. Neuroreport 1999, 10:3327-3331.
34. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr. Bull. 1987, 13:261-276.
35. Kindler J., Homan P., Jann K., Federspiel A., Flury R., et al. Reduced neuronal activity in language-related regions after transcranial magnetic stimulation therapy for auditory verbal hallucinations. Biol. Psychiatry 2013, 73:518-524.
36. Martinez-Granados B., Brotons O., Martinez-Bisbal M.C., Celda B., Marti-Bonmati L., et al. Spectroscopic metabolomic abnormalities in the thalamus related to auditory hallucinations in patients with schizophrenia. Schizophr. Res. 2008, 104:13-22.
37. Maudsley A.A., Darkazanli A., Alger J.R., Hall L.O., Schuff N., et al. Comprehensive processing, display and analysis for in vivo MR spectroscopic imaging. NMR Biomed. 2006, 19:492-503.
38. Miller B.L., Moats R.A., Shonk T., Ernst T., Woolley S., et al. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 1993, 187:433-437.
39. Ono M., Kubik S., Abernathey C. Atlas of the Cerebral Sulci 1990, Georg Thieme Verlag.
40. Poullet J.B., Sima D.M., Simonetti A.W., De Neuter B., Vanhamme L., et al. An automated quantitation of short echo time MRS spectra in an open source software environment: AQSES. NMR Biomed. 2007, 20:493-504.
41. Ratiney H., Coenradie Y., Cavassila S., van Ormondt D., Graveron-Demilly D. Time-domain quantitation of 1H short echo-time signals: background accommodation. MAGMA 2004, 16:284-296.
42. Schwerk A., Alves F.D., Pouwels P.J., van Amelsvoort T. Metabolic alterations associated with schizophrenia: a critical evaluation of proton magnetic resonance spectroscopy studies. J. Neurochem. 2014, 128:1-87.
43. Shergill S.S., Murray R.M., McGuire P.K. Auditory hallucinations: a review of psychological treatments. Schizophr. Res. 1998, 32:137-150.
44. Steen R.G., Hamer R.M., Lieberman J.A. Measurement of brain metabolites by 1H magnetic resonance spectroscopy in patients with schizophrenia: a systematic review and meta-analysis. Neuropsychopharmacology 2005, 30:1949-1962.
45. Stefan D., Di Cesare F., Andrasescu A., Popa E., Lazariev A., Vescovo E., Strbak O., Williams S., Starcuk Z., Cabanas M., van Ormondt D., Graveron-Demilly D. Quantitation of magnetic resonance spectroscopy signals: the jMRUI software package. Meas. Sci. Technol. 2009, 20.
46. Theberge J., Al-Semaan Y., Williamson P.C., Menon R.S., Neufeld R.W., et al. Glutamate and glutamine in the anterior cingulate and thalamus of medicated patients with chronic schizophrenia and healthy comparison subjects measured with 4.0-T proton MRS. Am. J. Psychiatry 2003, 160:2231-2233.
47. Uylings H.B., Rajkowska G., Sanz-Arigita E., Amunts K., Zilles K. Consequences of large interindividual variability for human brain atlases: converging macroscopical imaging and microscopical neuroanatomy. Anat. Embryol. (Berl.) 2005, 210:423-431.
48. van Swam C., Federspiel A., Hubl D., Wiest R., Boesch C., et al. Possible dysregulation of cortical plasticity in auditory verbal hallucinations-a cortical thickness study in schizophrenia. J. Psychiatr. Res. 2012, 46:1015-1023.
49. Xiong J., Rao S., Jerabek P., Zamarripa F., Woldorff M., et al. Intersubject variability in cortical activations during a complex language task. Neuroimage 2000, 12:326-339.
50. Yamada M., Wilber J.F. Reciprocal regulation of preprothyrotropin-releasing hormone (TRH) mRNA in the rat anterior hypothalamus by thyroid hormone: dissociation from TRH concentrations during hypothyroidism. Neuropeptides 1990, 15:49-53.